UNC Health Care

Tag: Infectious Diseases

Aravinda de Silva

April 18, 2017

De Silva lab awarded $3 million federal contract to develop Zika test

Researchers at the UNC School of Medicine are working to develop a test for the Zika virus that they hope will provide accurate results for a wide range of time between when an individual is potentially exposed to when he or she is tested for the virus.

Awards, Contagions, Zika

Read Article
Dr. David Weber

January 20, 2017

UV Light Can Aid Hospitals’ Fight to Wipe Out Drug-Resistant Superbugs

UNC's Dr. David Weber and Dr. William Rutala are co-authors of the study, which found that adding UV light to standard cleaning cut transmission of 4 resistant bacteria by 30 percent.

Research, Studies

Read Article
Lishan Su

December 14, 2016

Scientists find new way to reverse immune suppression caused by HIV

By blocking a specific cell signaling pathway in lab animals, researchers reversed signs of chronic immune activation, thereby boosting T-cell recovery and viral suppression.

HIV/AIDS, Immunology, Research

Read Article
drawing of HIV cells in body

November 30, 2016

‘To seek a true cure’: UNC researchers pioneer HIV research w...

In honor of World AIDS Day on Dec. 1, we take a look at the trailblazing ‘kick and kill’ method of attacking HIV to cure patients. UNC researchers have been working with GlaxoSmithKline on parallel studies at the UNC Cure Center for 18 months to advance this new method of combating the global epidemic of HIV.

Clinical Trials, HIV/AIDS

Read Article
Aravinda de Silva

November 11, 2016

Can nanotechnology help develop a workable dengue virus vaccine?

UNC School of Medicine researchers Aravinda de Silva, PhD, professor of microbiology and immunology, and Stefan Metz, PhD, are creating a nanoparticle vaccine that in experiments showed increased antibody responses against one serotype of dengue virus. The de Silva group is collaborating with the UNC laboratories of Chris Luft, PhD, (pharmacy and chemistry), Jenny Ting, PhD, (genetics), and Mike Miley,PhD, (pharmacology), as well as Liquidia Pharmaceuticals to use the same nanoparticle platform to develop a vaccine for all four serotypes of the virus.

Contagions, Research, Technology

Read Article
Mosquito.

November 4, 2016

UNC scientists named to European Union-funded global Zika research ...

The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.

Awards, Contagions

Read Article
David Weber

September 29, 2016

Weber delivers Zika, travel update to UNC School of Medicine faculty

David Weber, MD, MPH, Matt Collins, MD, PhD, and Helen Lazear, PhD, were the featured speakers addressing the Zika virus epidemic during lecture at the UNC School of Medicine.

Contagions, Research

Read Article
Jason Whitmire

September 15, 2016

UNC researchers identify how hepatitis A virus causes liver injury

A new report in the journal Science describes how the virus can jump species, including to mice – a finding that has major implications for researching the disease and host immune responses to the virus. Jason Whitmire, PhD, and Stanley Lemon, MD, led the research team.

Research

Read Article
David Margolis

August 13, 2016

UNC awarded nearly $23 million to continue national effort to cure HIV

The Collaboratory of AIDS Researchers for Eradication (CARE) at UNC is working on a “kick and kill” strategy to eradicate HIV from patients.

Awards, HIV/AIDS

Read Article
David Margolis

July 21, 2016

Researchers Discuss Challenges, Successes of HIV Cure Research in S...

A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.

HIV/AIDS, Research

Read Article